Attached files

file filename
10-Q - China Botanic Pharmaceuticalv225692_10q.htm
EX-31.1 - China Botanic Pharmaceuticalv225692_ex31-1.htm
EX-31.2 - China Botanic Pharmaceuticalv225692_ex31-2.htm
 
EXHIBIT 32
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of China Botanic Pharmaceutical Inc. (the “Registrant”) on Form 10-Q for the Quarter ended April 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Li Shaoming, chief executive officer and president of the Registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  June 14, 2011
/s/ Li Shaoming
 
Li Shaoming
 
Chief Executive Officer and President
 
(Principal Executive Officer)
 
In connection with the Quarterly Report of China Botanic Pharmaceutical Inc. (the “Registrant”) on Form 10-Q   for the Quarter ended April 30, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lu Xiaoying, interim chief financial officer of the Registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
 
Dated:  June 14, 2011
/s/ Weiqiu Dong
 
Weiqiu Dong
 
Chief Financial Officer
 
(Chief Accounting and Financial Officer)